Market cap
₹18 Cr
Revenue (TTM)
₹-3 Cr
P/E Ratio
--
P/B Ratio
1.8
Div. Yield
0 %
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
18 | 8,276 | 26 | 18 | 14 |
Revenue (₹ Cr) |
-3 | 7,644 | 2 | 562 | 33 |
Net Profit (₹ Cr) |
-0.07 | 191.80 | -1.15 | 1.24 | 1.27 |
Net Margin (%) |
2.62 | 2.50 | -63.68 | 0.22 | 3.86 |
RoE (%) |
-0.66 | 8.35 | -1.72 | 9.81 | 23.32 |
Price to Earnings |
-- | 59.39 | -- | 14.27 | 10.78 |
Price-To-Book |
1.79 | 4.66 | 0.39 | 9.36 | 2.86 |
Income Statement (₹ Cr)
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Operating Revenue
|
-2.97 | 7,644.02 | 12.55 | 562.10 | 32.61 |
|
Total Income
|
-2.52 | 7,659.63 | 20.47 | 562.10 | 32.91 |
|
Total Expenditure
|
-2.46 | 7,282.55 | 20.42 | 560.08 | 29.28 |
|
EBITDA
|
-0.52 | 361.47 | -7.87 | 2.02 | 3.33 |
|
Depreciation
|
0.00 | 50.02 | 1.82 | 0.01 | 0.09 |
|
EBIT
|
-0.52 | 311.44 | -9.69 | 2.01 | 3.25 |
|
Interest
|
0.00 | 75.03 | 0.00 | 0.00 | 0.48 |
|
Other Income
|
0.45 | 15.62 | 7.92 | 0.00 | 0.31 |
|
Exceptional Items
|
0.00 | -8.18 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-0.07 | 243.85 | -1.77 | 2.01 | 3.07 |
|
Provision for Tax
|
0.00 | 52.05 | 0.02 | 0.77 | 0.38 |
|
Profit after Tax
|
-0.07 | 191.80 | -1.78 | 1.24 | 2.69 |
Liabilities (₹ Cr)
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
9.70 | 1,781.11 | 111.61 | 23.23 | 7.51 |
|
Minority Interest
|
0.00 | -52.45 | 0.00 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
-0.01 | 343.92 | 1.14 | 0.00 | 2.21 |
|
Current Liabilities
|
-0.25 | 1,652.87 | 2.71 | 319.67 | 6.94 |
|
Total Liabilities
|
9.79 | 2,702.52 | 125.42 | 0.65 | -- |
Assets (₹ Cr)
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1.27 | 927.95 | 67.70 | 0.02 | 7.51 |
|
Current Assets
|
7.93 | 2,772.72 | 47.02 | 342.89 | 9.09 |
|
Total Assets
|
9.79 | 2,702.52 | 125.42 | 0.65 | -- |
|
Total Debt*
|
0.00 | 298.81 | 0.00 | 0.00 | -- |
|
Net Current Assets
|
8.18 | 1,119.86 | 44.31 | 23.21 | 2.15 |
|
Contingent Liabilities
|
1.72 | 4.01 | -- | -- | -- |
Cashflow (₹ Cr)
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
0.22 | -76.87 | 5.07 | 0.19 | -- |
|
Cash Flow from Investing Activities
|
-0.20 | 219.80 | -4.98 | -0.18 | -- |
|
Cash from Financing Activities
|
0.00 | -73.66 | -- | -- | -- |
|
Net Cash Inflow / Outflow
|
0.01 | 69.27 | 0.09 | 0.01 | -- |
Ratios
Profitability Ratios
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
ROCE (%)
|
2.66 | 9.16 | -0.66 | 9.64 | -- |
|
ROE (%)
|
-0.66 | 8.35 | -1.56 | 9.81 | 38.53 |
|
ROA (%)
|
-0.69 | 5.71 | -1.48 | 0.72 | 16.96 |
|
EBIT Margin (%)
|
17.33 | 4.07 | -77.24 | 0.36 | 9.96 |
|
Net Margin (%)
|
2.62 | 2.50 | -8.71 | 0.22 | 8.18 |
|
Cash Profit Margin (%)
|
29.75 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-150.48 | 34.75 | -42.88 | 4,540.45 | 18.48 |
|
EBIT Growth (%)
|
-266.67 | 77.19 | -45.53 | 1,710.81 | 480.86 |
|
Net Profit Growth (%)
|
-109.68 | 50.19 | 49.20 | 1,288.76 | 468.90 |
|
EPS Growth (%)
|
-109.68 | 31.10 | 49.20 | 1,322.31 | 139.83 |
|
Book Value Growth (%)
|
2.10 | 5.11 | 0.24 | 4.77 | -- |
Valuation Ratios
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-268.68 | 57.04 | -14.57 | 14.27 | 5.10 |
|
Price / Book Value
|
1.79 | 4.66 | 0.24 | 9.36 | 2.06 |
|
Dividend Yield (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
-24.93 | 23.66 | -0.26 | 8.74 | 6.06 |
|
Market Cap (₹ Cr)
|
19.85 | 4,944.94 | 51.76 | 6.99 | -- |
Solvency Ratios
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.11 | 0.00 | 0.00 | 0.28 |
|
Short term debt to equity ratio
|
-- | 0.17 | -- | -- | -- |
|
Current Ratio
|
-31.58 | 1.68 | 17.35 | 1.07 | 1.31 |
|
Quick Ratio
|
-30.28 | 1.15 | 16.26 | 1.07 | 0.42 |
|
Interest Coverage
|
-65.00 | 4.25 | -16.63 | 10.12 | 7.40 |
Operating Efficiency Ratios
| Pentokey Organy | Entero Health | Medi-Caps | Rubra Medicaments | Maitri Enterprises | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-39.13 | 19.11 | 55.16 | 60.08 | 3.91 |
|
Asset Turnover
|
-0.31 | 2.27 | 0.10 | 3.27 | 2.05 |
|
Receivable days
|
482.34 | 51.78 | 140.45 | 362.19 | -- |
|
Inventory Days
|
144.64 | 38.71 | 64.01 | 0.00 | -- |
|
Payable days
|
44.32 | 24.83 | 63.40 | -- | -- |
|
Cash Conversion Cycle
|
582.66 | 65.66 | 141.06 | -- | -- |